Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

news

News
Leading Their Patients on the Psychedelic Therapy Journey: Considerations for Clinicians
09/18/2021
Heather Flint, Senior Digital Managing Editor
There are several “important considerations for the clinician” in preparing to help lead their client on the journey of psychedelic therapies, said Julie Megler, PHH-NP, at today’s SANA Symposium.
There are several “important considerations for the clinician” in preparing to help lead their client on the journey of psychedelic therapies, said Julie Megler, PHH-NP, at today’s SANA Symposium.
There are several “important...
09/18/2021
Psych Congress Network
News
‘Container’ Creates an Ideal Home for Psychedelic Therapy
09/17/2021
Tom Valentino, Senior Editor
Andrew Penn, NP, and Saundra Jain, MA, PsyD, LPC, discussed the key components of a therapeutic relationship and creating an optimal environment for healing in psychedelic therapy during their Friday session at the Sana Symposium.
Andrew Penn, NP, and Saundra Jain, MA, PsyD, LPC, discussed the key components of a therapeutic relationship and creating an optimal environment for healing in psychedelic therapy during their Friday session at the Sana Symposium.
Andrew Penn, NP, and Saundra...
09/17/2021
Psych Congress Network
News
‘Container’ Creates an Ideal Home for Psychedelic Therapy
09/17/2021
Tom Valentino, Senior Editor
Andrew Penn, NP, and Saundra Jain, MA, PsyD, LPC, discussed the key components of a therapeutic relationship and creating an optimal environment for healing in psychedelic therapy during their Friday session at the Sana Symposium.
Andrew Penn, NP, and Saundra Jain, MA, PsyD, LPC, discussed the key components of a therapeutic relationship and creating an optimal environment for healing in psychedelic therapy during their Friday session at the Sana Symposium.
Andrew Penn, NP, and Saundra...
09/17/2021
Psych Congress Network
News
‘Bright’ Yet Cautionary Future for Psychedelics as Evidence-Based Medicine
09/17/2021
Meagan Thistle
The future of psychedelic medicine is rapidly emerging and clinicians should continue to follow this research before eventually accepting these drugs into their clinical practice, says Rakesh Jain, MD, MPH.
The future of psychedelic medicine is rapidly emerging and clinicians should continue to follow this research before eventually accepting these drugs into their clinical practice, says Rakesh Jain, MD, MPH.
The future of psychedelic...
09/17/2021
Psych Congress Network
News
‘Bright’ Yet Cautionary Future for Psychedelics as Evidence-Based Medicine
09/17/2021
Meagan Thistle
The future of psychedelic medicine is rapidly emerging and clinicians should continue to follow this research before eventually accepting these drugs into their clinical practice, says Rakesh Jain, MD, MPH.
The future of psychedelic medicine is rapidly emerging and clinicians should continue to follow this research before eventually accepting these drugs into their clinical practice, says Rakesh Jain, MD, MPH.
The future of psychedelic...
09/17/2021
Psych Congress Network
News
“Egoic Style of Thinking” Allows Psychedelic Effects in the Human Brain
09/17/2021
Meagan Thistle
The “pivotal mental state,” made possible by the hyperplasticity of the brain, is where one pivots from “wellness” or “illness” when undergoing adaptive pressure or in a psychedelic state, Dr Carhart-Harris, told virtual attendees.
The “pivotal mental state,” made possible by the hyperplasticity of the brain, is where one pivots from “wellness” or “illness” when undergoing adaptive pressure or in a psychedelic state, Dr Carhart-Harris, told virtual attendees.
The “pivotal mental state,” made...
09/17/2021
Psych Congress Network
News
“Egoic Style of Thinking” Allows Psychedelic Effects in the Human Brain
09/17/2021
Meagan Thistle
The “pivotal mental state,” made possible by the hyperplasticity of the brain, is where one pivots from “wellness” or “illness” when undergoing adaptive pressure or in a psychedelic state, Dr Carhart-Harris, told virtual attendees.
The “pivotal mental state,” made possible by the hyperplasticity of the brain, is where one pivots from “wellness” or “illness” when undergoing adaptive pressure or in a psychedelic state, Dr Carhart-Harris, told virtual attendees.
The “pivotal mental state,” made...
09/17/2021
Psych Congress Network
News
Association President: Psychedelics Emerging, but Obstacles to Mainstream Model Remain
09/14/2021
Tom Valentino, Senior Editor
Ahead of her sessions at the Sana Symposium, Lynn Marie Morski, MD, JD, president of the Psychedelic Medicine Association, discusses the path forward for psychedelic therapies fitting into the mainstream medical model and their potential...
Ahead of her sessions at the Sana Symposium, Lynn Marie Morski, MD, JD, president of the Psychedelic Medicine Association, discusses the path forward for psychedelic therapies fitting into the mainstream medical model and their potential...
Ahead of her sessions at the...
09/14/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Popular Now

News
University Research Sheds Light on Relapse Factors for Hazelden Betty Ford
01/28/2021
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
A partnership with students at...
01/28/2021
Addiction Professional
Quiz
Quiz: Risk Factors for Tardive Dyskinesia
07/15/2020
Which of the following is a risk factor for tardive dyskinesia (TD): age, diagnosis of schizophrenia, comorbid bipolar and related disorders, history of extrapyramidal symptoms, or all of these?
Which of the following is a risk factor for tardive dyskinesia (TD): age, diagnosis of schizophrenia, comorbid bipolar and related disorders, history of extrapyramidal symptoms, or all of these?
Which of the following is a risk...
07/15/2020
Psychiatry & Behavioral Health
Contingency Management Rates Best in Comparison of Treatments for Cocaine Use Disorder
05/11/2021
In a meta-analysis of 157 clinical trials, contingency management programs were found to be the most beneficial treatment modality for cocaine use disorder among adults. Findings, compiled by researchers from Stanford University, Veterans...
In a meta-analysis of 157 clinical trials, contingency management programs were found to be the most beneficial treatment modality for cocaine use disorder among adults. Findings, compiled by researchers from Stanford University, Veterans...
In a meta-analysis of 157...
05/11/2021
Addiction Professional
Faculty Q&A
Q&A: Updates From Dr. Rakesh Jain on Managing Tardive Dyskinesia
06/15/2021
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, is educating mental health clinicians on the latest research and strategies for treating tardive dyskinesia during the 2020 series of Psych Congress...
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, is educating mental health clinicians on the latest research and strategies for treating tardive dyskinesia during the 2020 series of Psych Congress...
Psych Congress Steering...
06/15/2021
Psychiatry & Behavioral Health
Education
Continuing Education: Individualized Insomnia Strategies in Psychiatric Populations: Management Solutions for the Entire Care Team
07/01/2021
07/01/2021
Psychiatry & Behavioral Health

Advertisement

Advertisement

Advertisement

Sign Up

Psychiatry & Behavioral Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use